SCHEMBL6322360

SCHEMBL6322360

Cc1cc(C)c2c(n1)NCCC2=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UHRF1 Q96T88 1/20 0.53
KMT2A Q03164 3/20 0.33
ALDH1A1 P00352 3/20 0.33
MEN1 O00255 2/20 0.33
GAA P10253 2/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
ALOX12 P18054 1/20 0.33
CASP1 P29466 1/20 0.33
MPI P34949 1/20 0.33
HTT P42858 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
IGF1R P08069 1/20 0.32
DRD1 P21728 1/20 0.31
CDC7 O00311 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18369760 0.74 UHRF1 (0.82) UHRF1KMT2AALDH1A1MEN1IGF1R
SCHEMBL10286563 0.72 UHRF1 (0.41) UHRF1KMT2AALDH1A1MEN1GAA
SCHEMBL4241202 0.70 MEN1 (0.41) UHRF1KMT2AALDH1A1MEN1GAA
SCHEMBL6325164 0.69 UHRF1 (1.00) UHRF1KMT2AALDH1A1MEN1GAA
SCHEMBL7916071 0.68 TSHR (0.44) UHRF1KMT2AALDH1A1LMNAHPGD
SCHEMBL8067184 0.64 UHRF1 (0.70) UHRF1KMT2AALDH1A1MEN1GAA
SCHEMBL31600787 0.64 UHRF1 (0.56) UHRF1KMT2AALDH1A1MEN1GAA
SCHEMBL10286569 0.63 MEN1 (0.35) UHRF1KMT2AALDH1A1MEN1GAA
SCHEMBL10286500 0.63 MEN1 (0.49) UHRF1KMT2AALDH1A1MEN1GAA
SCHEMBL20416986 0.63 UHRF1 (0.50) UHRF1ALDH1A1GAAHPGDCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004200-A1 Pyrazole compounds as integrin receptor antagonists derivatives PHARMACIA CORPORATION 2005-01-06 US disclosed
WO-2004058761-A1 PYRAZOLE COMPOUNDS AS INTEGRIN RECEPTOR ANTAGONISTS DERIVATIVES PHARMACIA CORPORATION (US) 2004-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004200-A1 Pyrazole compounds as integrin receptor antagonists derivatives ITGA5, ITGB3, ITGB5 UHRF1 4856/4885KMT2A 4015/4885ALDH1A1 2040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.